AMENDMENT TO CONVERTIBLE LOAN AGREEMENTSConvertible Loan Agreements • March 5th, 2020 • Rimon Gold Assets LTD • Pharmaceutical preparations
This Amendment to Convertible Loan Agreements (this “Amendment”), dated as of November 28, 2019 and effective November 29, 2019, is entered into by and among Wize Pharma Ltd., an Israeli private company #520033259 (the “Company”), Wize Pharma, Inc. (“Parent”), Rimon Gold Assets Ltd., an Israeli private company #514819424 (“Rimon Gold’’), Mobigo Inc (“Mobigo”), and Shimshon Fisher (“Fisher”, together with Rimon Gold and Mobigo, the “Lenders”).
JOINT FILING AGREEMENTJoint Filing Agreement • November 28th, 2017 • Rimon Gold Assets LTD • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of stock of Wize Pharma, Inc.
